{"SPADE_UN_11332": {"Clinical Information": [{"Medical use": "antimicrobial-peptide-containing mouth wash for the treatment of oral candidiasis (gingivitis and periodontal diseases)", "Company": "Demgen and Dow Pharmaceutical Sciences;licensed to the Vancouver, Canada, company Pacgen", "Stage of Development": "Phase II-III", "Comments": "In a randomised double-blind clinical trial in 106 subjects, histatin derivatives were found to be more effective than placebo in preventing experimental gingivitis", "Clinical Trials": []}], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11332", "Peptide Name": "Histatin", "Sequence": "DXHEKRHHGYRRKFHEKHHSHREFPFYGDYGSNYLYDN", "Source": "using a variant of histatins, which are naturally occurring cationic peptides in saliva", "Target Organism": "Histatins manifest an in vivo IC50 value of approximately 1.4 Î¼M", "Reference": ["Histatins: antimicrobial peptides with therapeutic potential. J. Pharm. Pharmacol. (2004).(PMID:15025852)", "Safety and clinical effects of topical histatin gels in human with experimental gingivitis. J Clin Periodontol (2002)(PMID:12492903)"], "Biological Activity": ["Antifungal", "mitochondrion)"], "Frequent Amino Acids": "HYR", "Absent Amino Acids": "ACIMOQTUVW", "Basic Residues": 14, "Acidic Residues": 6, "Hydrophobic Residues": 10, "Polar Residues": 23, "Positive Residues": 14, "Negative Residues": 6, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_11332", "Similarity": 1.0, "Sequence": "DHEKRHHGYRRKFHEKHHSHREFPFYGDYGSNYLYDN"}, {"SPADE_ID": "SPADE_N_03134", "Similarity": 1.0, "Sequence": "RKFHEKHHSHREFPFYGDYGSNYLYDN"}, {"SPADE_ID": "SPADE_N_03133", "Similarity": 0.972972972972973, "Sequence": "DSHEKRHHGYRRKFHEKHHSHREFPFYGDYGSNYLYDN"}]}}}